Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
HIRAKAWA HEWTECH, Last Fiscal Year's Ordinary Profit Exceeds Expectations, 21% Increase in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 2 yen
5821 HIRAKAWA HEWTECH CORP. 【J-GAAP】
Earnings ReportHIRAKAWA HEWTECH CORP. <5821> [TSE Prime] announced its financial results after the market closed on May 9th (15:30). The consolidated ordinary profit for the fiscal year ending March 2025 increased 22.9% from the previous period to 2.55 billion yen, exceeding the previous forecast of 2.21 billion yen. For the fiscal year ending March 2026, the consolidated ordinary profit is expected to grow by 21.2% to 3.1 billion yen.
At the same time, the company has decided to increase the dividend this fiscal year to 47 yen, an increase of 2 yen from the previous fiscal year.
In the most recent three-month period, from January to March (4Q), the consolidated ordinary profit decreased to 0.37 billion yen, a 16.2% decrease compared to the same period last year. However, the operating profit margin significantly improved from 4.9% in the same period last year to 8.7%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2023 | 32,224 | 3,103 | 3,501 | 2,955 | 210.4 | 36 | May 10, 2023 | J-GAAP |
| Mar, 2024 | 29,326 | 1,667 | 2,081 | 1,444 | 102.8 | 36 | May 9, 2024 | J-GAAP |
| Mar, 2025 | 30,802 | 2,267 | 2,557 | 2,026 | 137.4 | 45 | May 9, 2025 | J-GAAP |
| YoY | +5.0% | +36.0% | +22.9% | +40.3% | +33.6% |
Full Year Results vs. Previous Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2025 Guidance | 31,300 | 1,940 | 2,210 | 1,640 | 116.8 | 45 | May 9, 2024 | J-GAAP |
| Mar, 2025 Results | 30,802 | 2,267 | 2,557 | 2,026 | 137.4 | 45 | May 9, 2025 | J-GAAP |
| Revision Rate | -1.6% | +16.9% | +15.7% | +23.5% | +17.7% |
Current Period Guidance
H1 Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Sep, 2024 | 16,020 | 1,251 | 1,307 | 1,005 | 71.6 | 22 | Nov 1, 2024 | J-GAAP |
| Apr - Sep, 2025 Guidance | ー | ー | ー | ー | - | 23 | May 9, 2025 | J-GAAP |
| YoY | - | - | - | - | - |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2024 | 29,326 | 1,667 | 2,081 | 1,444 | 102.8 | 36 | May 9, 2024 | J-GAAP |
| Mar, 2025 | 30,802 | 2,267 | 2,557 | 2,026 | 137.4 | 45 | May 9, 2025 | J-GAAP |
| Mar, 2026 Guidance | 35,000 | 3,000 | 3,100 | 2,300 | 155.4 | 47 | May 9, 2025 | J-GAAP |
| YoY | +13.6% | +32.3% | +21.2% | +13.5% | +13.1% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Mar, 2024 | 6,979 | 340 | 451 | 614 | 43.7 | 4.9 | May 9, 2024 | J-GAAP |
| Apr - Jun, 2024 | 8,128 | 629 | 972 | 721 | 51.3 | 7.7 | Aug 1, 2024 | J-GAAP |
| Jul - Sep, 2024 | 7,892 | 622 | 335 | 284 | 20.2 | 7.9 | Nov 1, 2024 | J-GAAP |
| Oct - Dec, 2024 | 7,450 | 381 | 872 | 584 | 41.6 | 5.1 | Feb 4, 2025 | J-GAAP |
| Jan - Mar, 2025 | 7,332 | 635 | 378 | 437 | 29.6 | 8.7 | May 9, 2025 | J-GAAP |
| YoY | +5.1% | +86.8% | -16.2% | -28.8% | -32.2% |
Related Articles
Oncolys BioPharma, Jan-Mar (1Q) Net Income Loss Widens
JAPAN CASH MACHINE, 79% Decrease in Ordinary Profit for The Current Fiscal Year
NITTO BOSEKI, 3% Decrease in Ordinary Profit for The Current Fiscal Year, Increased Previous Year's Dividend by 19 yen
DOSHISHA, 7% Increase in Ordinary Profit, Record High for The First Time in Five Years, Dividend Raised by 15 yen
Medrx, Jan-Mar (1Q) Ordinary Profit Loss Widens
KOSE, Jan-Mar (1Q) Ordinary Profit Decreases by 50%
SHIMA SEIKI MFG, Returning to Profitability This Year, Dividend Raised by 10 yen
AUTOBACS SEVEN, 8% Increase in Ordinary Profit for The Current Fiscal Year
SUSMED, Jul-Mar (Cumulative 3Q) Ordinary Profit Loss Narrows, Jan-Mar Ordinary Profit Turns to Profit
Noritsu Koki, The Current Fiscal Year Net Income Revised Downward by 9%